Enterprise HL7 / FHIR Terminology Engine

Universal Clinical Codes & Terminology Search

Search, verify, and inspect standardized LOINC, SNOMED CT, ICD-10-CM, RxNorm, and CPT clinical codes with native HL7 FHIR R4 resource mappings.

/
Showing 20 of 12623 codes
Per page:
Need to map or validate codes in bulk?
Cross-reference up to 1,000 ICD-10, LOINC, and CPT records simultaneously in memory with our free utility.
Open Bulk Crosswalk Tool →
Code Value Display Description Code System & OID FHIR Resource Category Status Actions
0619U
Pulmonary (chronic obstructive pulmonary disease [COPD]) DNA methylation analysis of more than 18000 sites whole blood algorithm reported as positive or negative risk
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0620U
Oncology (hepatocellular carcinoma) DNA methylation analysis of more than 5000 sites whole blood algorithm reported as positive or negative risk
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0621U
Infectious disease (Lyme borreliosis) DNA methylation analysis of more than 10000 sites whole blood algorithm reported as positive or negative risk
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0622U
Psychiatry (major depressive disorder) DNA methylation analysis of more than 20000 sites whole blood algorithm reported as positive or negative risk
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0623T
Automated quantification and characterization of coronary atherosclerotic plaque to assess severity of coronary disease using data from coronary computed tomographic angiography; data preparation and transmission computerized analysis of data with review of computerized analysis output to reconcile discordant data interpretation and report
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0623U
Autoimmune (multiple sclerosis) DNA methylation analysis of more than 5000 sites whole blood algorithm reported as positive or negative risk
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0624T
Automated quantification and characterization of coronary atherosclerotic plaque to assess severity of coronary disease using data from coronary computed tomographic angiography; data preparation and transmission
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0624U
Hepatology (nonalcoholic steatohepatitis [NASH]) DNA methylation analysis of 5000 sites whole blood algorithm reported as positive or negative risk
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0625T
Automated quantification and characterization of coronary atherosclerotic plaque to assess severity of coronary disease using data from coronary computed tomographic angiography; computerized analysis of data from coronary computed tomographic angiography
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0625U
Endocrinology (osteoporosis) DNA methylation analysis of more than 5000 sites whole blood algorithm reported as positive or negative risk
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0626T
Automated quantification and characterization of coronary atherosclerotic plaque to assess severity of coronary disease using data from coronary computed tomographic angiography; review of computerized analysis output to reconcile discordant data interpretation and report
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0626U
Neurology (Parkinson disease) DNA methylation analysis of more than 20000 sites whole blood algorithm reported as positive or negative risk
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0627U
Psychiatry (schizophrenia) DNA methylation analysis of more than 15000 sites whole blood algorithm reported as positive or negative risk
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0628U
Nephrology (kidney disease-related genetic conditions) genomic analysis renal disease panel saliva DNA next-generation sequencing of 449 genes reported as pathogenic or likely pathogenic variants of uncertain significance or risk alleles
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0629U
Infectious disease (tuberculosis) DNA analysis of 1 target by PCR with clustered regularly interspaced short palindromic repeat (CRISPR)-based probe detection plasma or serum qualitative report as detected or not detected
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0630U
Oncology (breast) mRNA gene expression profiling by microarray of 80 genes (80 content and 465 housekeeping) utilizing formalin-fixed paraffin-embedded tissue (FFPE) algorithm reported as an index that is diagnostic of a molecular subtype (luminal basal Her2)
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0631T
Transcutaneous visible light hyperspectral imaging measurement of oxyhemoglobin deoxyhemoglobin and tissue oxygenation with interpretation and report per extremity
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0633T
Ct breast w/3d uni c-
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0634T
Ct breast w/3d uni c+
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
0635T
Ct breast w/3d uni c-/c+
 CPT
2.16.840.1.113883.6.12
Procedures Procedures Active
Page 68 of 632
Healthcare Terminology & FHIR R4 Interoperability
Standardized coding guidelines governed by CodesForMD

In HL7 FHIR R4, discrete clinical findings and laboratory measurements are encapsulated inside Observation resources. Diagnostic terms and problem list entries are represented within Condition resources, while surgical and therapeutic acts map to Procedure. CodesForMD adheres to official US Core and International FHIR Implementation Guides.

An OID is an internationally standardized dotted-decimal identifier (e.g. 2.16.840.1.113883.6.1 for LOINC) registered with HL7 and ISO. OIDs ensure unambiguous identification of terminology authorities when exchanging clinical messages across heterogeneous EHR, LIS, and PACS systems.

Yes. You can visit our platform's administrative ingestion and export engine or contact our team to obtain batch files of standardized codes.
Copied to clipboard!